These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses. Kida E; Golabek AA; Wisniewski KE Adv Genet; 2001; 45():35-68. PubMed ID: 11332776 [TBL] [Abstract][Full Text] [Related]
3. Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Kousi M; Lehesjoki AE; Mole SE Hum Mutat; 2012 Jan; 33(1):42-63. PubMed ID: 21990111 [TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic characterization of neuronal ceroid lipofuscinoses (NCLs) in 29 Iranian patients: identification of 11 novel mutations. Panjeshahi S; Karimzadeh P; Movafagh A; Ahmadabadi F; Rahimian E; Alijanpour S; Miryounesi M Hum Genet; 2023 Aug; 142(8):1001-1016. PubMed ID: 37074398 [TBL] [Abstract][Full Text] [Related]
8. Cell biology of the NCL proteins: What they do and don't do. Cárcel-Trullols J; Kovács AD; Pearce DA Biochim Biophys Acta; 2015 Oct; 1852(10 Pt B):2242-55. PubMed ID: 25962910 [TBL] [Abstract][Full Text] [Related]
9. Human pathology in NCL. Anderson GW; Goebel HH; Simonati A Biochim Biophys Acta; 2013 Nov; 1832(11):1807-26. PubMed ID: 23200925 [TBL] [Abstract][Full Text] [Related]
12. Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5. Mole SE; Mitchison HM; Munroe PB Hum Mutat; 1999; 14(3):199-215. PubMed ID: 10477428 [TBL] [Abstract][Full Text] [Related]
13. Molecular diagnosis of and carrier screening for the neuronal ceroid lipofuscinoses. Zhong NA; Wisniewski KE; Ju W; Moroziewicz DN; Jurkiewicz A; McLendon L; Jenkins EC; Brown WT Genet Test; 2000; 4(3):243-8. PubMed ID: 11142754 [TBL] [Abstract][Full Text] [Related]
14. The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease. Weimer JM; Kriscenski-Perry E; Elshatory Y; Pearce DA Neuromolecular Med; 2002; 1(2):111-24. PubMed ID: 12025857 [TBL] [Abstract][Full Text] [Related]
15. Molecular genetics of the neuronal ceroid lipofuscinoses. Mole S; Gardiner M Epilepsia; 1999; 40 Suppl 3():29-32. PubMed ID: 10446748 [TBL] [Abstract][Full Text] [Related]
16. Mutations in CLN7/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis. Kousi M; Siintola E; Dvorakova L; Vlaskova H; Turnbull J; Topcu M; Yuksel D; Gokben S; Minassian BA; Elleder M; Mole SE; Lehesjoki AE Brain; 2009 Mar; 132(Pt 3):810-9. PubMed ID: 19201763 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and molecular characterization of neuronal ceroid lipofuscinosis in the Portuguese population. Teixeira C; Guimarães A; Bessa C; Ferreira MJ; Lopes L; Pinto E; Pinto R; Boustany RM; Sá Miranda MC; Ribeiro MG J Neurol; 2003 Jun; 250(6):661-7. PubMed ID: 12796825 [TBL] [Abstract][Full Text] [Related]
18. The neuronal ceroid-lipofuscinoses (Batten disease): a new class of lysosomal storage diseases. Bennett MJ; Hofmann SL J Inherit Metab Dis; 1999 Jun; 22(4):535-44. PubMed ID: 10407785 [TBL] [Abstract][Full Text] [Related]
19. Loci for classical and a variant late infantile neuronal ceroid lipofuscinosis map to chromosomes 11p15 and 15q21-23. Sharp JD; Wheeler RB; Lake BD; Savukoski M; Järvelä IE; Peltonen L; Gardiner RM; Williams RE Hum Mol Genet; 1997 Apr; 6(4):591-5. PubMed ID: 9097964 [TBL] [Abstract][Full Text] [Related]